Arca
Skip to content

Advia Centaur B-Type Natriuretic Peptide (Bnp) Assay

Test, Natriuretic Peptide. 510(k) K031038, from Bayer Healthcare, LLC (Tarrytown, NY). Product code NBC, class 2.

As of Nov 17, 2026, K031038 is an FDA 510(k) held by Bayer Healthcare, LLC, substantially equivalent on Jun 23, 2003 after 83 days, with 6 recalls tied to it in FDA's recall database.

  • Substantially equivalent: Jun 23, 2003
  • Review time: 83 days
  • Recalls: 6
  • Cited as a predicate by: 3 devices

Indications for Use

As the 510(k) summary states them, read from FDA's summary PDF

For in vitro diagnostic use in the quantitative determination of B-type Natriuretic Peptide (BNP) in human plasma using the ADVIA Centaur® System. This assay is indicated for the measurement of plasma BNP as an aid in the diagnosis of heart failure. This assay is not intended for use on any other system. Office of In Vitro Diagnostic Device Evaluation and Safety 510(k) K 0 31 0 38

Predicate Devices

The legally marketed devices this 510(k) summary says it is substantially equivalent to, read from FDA's summary PDF

Cited as a Predicate

3 later 510(k) summaries name this device as a predicate

Recalls

Recalls FDA ties to K031038, newest first; each opens FDA's recall record
Dec 18, 2017Z-2053-2018In certain scenarios the ADVIA Centaur CP, XP and XPT immunoassay analyzers may exhibit reduced dilution recovery or become inoperable when used with Multi-Diluent 15 and certain lots of BNP and TSH3RUL Assays.Open, Classified
Oct 6, 2014Z-0229-2015Siemens Healthcare Diagnostics has confirmed that approximately 2000 ReadyPacks from the ADVIA Centaur Systems BNP reagent contains an ADVIA Centaur Systems FT4 human-readable side label.Terminated
Jun 23, 2014Z-2150-2014Complaints of failed calibration.Terminated
Jun 23, 2014Z-2149-2014Complaints of failed calibration.Terminated
Nov 14, 2012Z-0506-2013Operating range of the ADVIA Centaur systems is 18C to 30C (64.4F to 86.0F), a change in room temperature may increase or decrease assay results, depending on the specific assay and ADVIA Centaur system used.Terminated
Jul 25, 2012Z-2313-2012Decrease in onboard dilution recovery when using Multi-Diluent 1 that has been stored on board the ADVIA Centaur and ADVIA Centaur XP systems for for BNP and TSH3 Ultra assaysTerminated

Other NBC Clearances

The newest 510(k)s for the same product code; their median review was 257 days; see every NBC device

Record

Type
Traditional
Received
Apr 1, 2003
Review panel
Clinical Chemistry
Regulation
21 CFR 862.1117

One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files

Logos are each company's own site icon, matched by name through Wikidata.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.